About Alvio Pharmaceuticals
Alvio Pharmaceuticals is a Healthcare company based in Ahmedabad (India). Markets affordable pharmaceutical products across therapeutic areas in India. It operates on a B2B and B2C model. The company has 171 employees. Its Indian entity Alvio Pharmaceuticals Private Limited reported revenue of ₹37.10 Cr. Alvio Pharmaceuticals offers products and services including Cardio-Diabetic Products, Gastro Products, Antibiotics, and Nutraceuticals. Its focus areas include Pharmaceuticals, Therapeutic Areas, Nutraceuticals and Chronic Therapy. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Alvio Pharmaceuticals is a company that markets finished pharmaceutical formulations, focusing on improving lives through high-quality and affordable healthcare options. It operates nationally in India, covering segments like chronic therapy, derma, and nutraceuticals. The company partners with manufacturers and reaches medical professionals, offering products such as cardio-diabetic and antibiotics. Based in Ahmedabad and Roorkee, it aims to support patients in managing health challenges.
- Headquarters Ahmedabad, India
- Employees 171
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website alviopharma.com
- Social LinkedIn Facebook
- Legal Name Alvio Pharmaceuticals Private Limited
- Date of Incorporation 25 Jan, 2008
- Jurisdiction Sarkhej, Gujarat, India
- Annual Revenue₹37.10 Cr
FY 2025 · +7% YoY
- Net Profit₹2.33 Cr
FY 2025 · 6% margin
- EBITDA₹5.26 Cr
FY 2025 · 14% margin
- Employee Count171
Associated legal entities of Alvio Pharmaceuticals
Alvio Pharmaceuticals operates through Alvio Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Alvio Pharmaceuticals Private Limited CIN U24100GJ2008PTC092271 | Active | 25 Jan 2008 | Sarkhej, Gujarat | ₹37.1 Cr | 171 | 2 | View details |
Products & Services of Alvio Pharmaceuticals
Alvio Pharmaceuticals offers a comprehensive portfolio of products and services, including Cardio-Diabetic Products, Gastro Products, Antibiotics, and Nutraceuticals.
Products for managing cardiovascular and diabetic conditions.
Formulations for gastrointestinal health treatments.
Medications for treating bacterial infections.
Supplements enhancing health and wellness.
Board of directors of Alvio Pharmaceuticals Private Limited (Alvio Pharmaceuticals)
Alvio Pharmaceuticals Private Limited is the primary company behind Alvio Pharmaceuticals. The board of Alvio Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Manish Kumar Dudhwewala, appointed in 2008. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manish Kumar Dudhwewala DIN 00674856 | Whole-time director | 07 Feb 2008 | 18 yrs 9 mo | Alvio Pharmaceuticals Private Limited |
| Nilesh Kumar Dudhwewala DIN 00714281 | Whole-time director | 07 Oct 2015 | 11 yrs 1 mo | Alvio Pharmaceuticals Private Limited |
Financials of Alvio Pharmaceuticals
Figures of Alvio Pharmaceuticals Private Limited, the primary company behind Alvio Pharmaceuticals, for FY 2025. Revenue was ₹37.10 Cr (+7% year on year). Net profit was ₹2.33 Cr (6% margin). EBITDA was ₹5.26 Cr (14% margin). Revenue has grown at a compounded annual rate of +2% over three years and +3% over five years.
- ₹37.10 CrRevenue · FY 2025 · +7% YoY
- ₹2.33 CrNet profit · 6% margin
- ₹5.26 CrEBITDA · 14% margin
- ₹4.27 CrPaid-up capital
- 171Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Alvio Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Alvio Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Alvio Pharmaceuticals
Alvio Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Alvio Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Alvio Pharmaceuticals (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 55.41 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 56.21 M | 144 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alvio Pharmaceuticals
Alvio Pharmaceuticals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Alvio Pharmaceuticals has 171 employees.
The primary company behind Alvio Pharmaceuticals, Alvio Pharmaceuticals Private Limited, reported revenue of ₹37.10 Cr for FY 2025, up 7% year on year.
Alvio Pharmaceuticals is a company that markets finished pharmaceutical formulations, focusing on improving lives through high-quality and affordable healthcare options. It operates nationally in India, covering segments like chronic therapy, derma, and nutraceuticals. The company partners with manufacturers and reaches medical professionals, offering products such as cardio-diabetic and antibiotics. Based in Ahmedabad and Roorkee, it aims to support patients in managing health challenges.
Alvio Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Alvio Pharmaceuticals offers Cardio-Diabetic Products, Gastro Products, Antibiotics, and Nutraceuticals.
Alvio Pharmaceuticals operates through Alvio Pharmaceuticals Private Limited.
The legal entities of Alvio Pharmaceuticals currently have 2 directors, including Manish Kumar Dudhwewala, Nilesh Kumar Dudhwewala.